000 01655 a2200433 4500
005 20250511201646.0
264 0 _c19910801
008 199108s 0 0 eng d
022 _a0022-1007
024 7 _a10.1084/jem.174.1.35
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLublin, D M
245 0 0 _aPhospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
_h[electronic resource]
260 _bThe Journal of experimental medicine
_cJul 1991
300 _a35-44 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntigens, CD
650 0 4 _aCD55 Antigens
650 0 4 _aCell Membrane
_xphysiology
650 0 4 _aCell Survival
650 0 4 _aComplement C3
_xphysiology
650 0 4 _aComplement Inactivator Proteins
_xphysiology
650 0 4 _aComplement System Proteins
_xphysiology
650 0 4 _aDNA
_xgenetics
650 0 4 _aFlow Cytometry
650 0 4 _aGlycolipids
_xphysiology
650 0 4 _aGlycosylphosphatidylinositols
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aMembrane Cofactor Protein
650 0 4 _aMembrane Glycoproteins
_xgenetics
650 0 4 _aMembrane Proteins
_xgenetics
650 0 4 _aPhosphatidylinositols
_xphysiology
650 0 4 _aTransfection
700 1 _aCoyne, K E
773 0 _tThe Journal of experimental medicine
_gvol. 174
_gno. 1
_gp. 35-44
856 4 0 _uhttps://doi.org/10.1084/jem.174.1.35
_zAvailable from publisher's website
999 _c1717967
_d1717967